Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 20, 2019 - Issue 9
Submit an article Journal homepage
372
Views
3
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Dapagliflozin and cardiovascular outcomes: anything else to DECLARE?

Emanuel RaschiPharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, ItalyCorrespondence[email protected]
View further author information
,
Elisabetta PoluzziPharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, ItalyView further author information
,
Giulio MarchesiniUnit of Metabolic Diseases & Clinical Dietetics, Department of Medical and Surgical Sciences, University of Bologna, Bologna, ItalyView further author information
&
Fabrizio De PontiPharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, ItalyView further author information
Pages 1087-1090 | Received 06 Dec 2018, Accepted 20 Mar 2019, Published online: 28 Mar 2019

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Emanuel Raschi, Gian Paolo Fadini, Igor Diemberger, Elisabetta Poluzzi & Fabrizio De Ponti. (2021) SGLT2 inhibitors for heart failure with reduced ejection fraction: a real EMPEROR?. Expert Opinion on Pharmacotherapy 22:5, pages 647-650.
Read now

Articles from other publishers (2)

Nicola Fleming, Peter Shane Hamblin, David Story & Elif I Ekinci. (2020) Evolving Evidence of Diabetic Ketoacidosis in Patients Taking Sodium-Glucose Cotransporter 2 Inhibitors. The Journal of Clinical Endocrinology & Metabolism 105:8, pages 2475-2486.
Crossref
David H. Manner, Chakib Battioui, Stefan Hantel, B. Nhi Beasley, Lee-Jen Wei, Mary Jane Geiger, J. Rick Turner & Markus Abt. (2019) Restricted mean survival time for the analysis of cardiovascular outcome trials assessing non-inferiority: Case studies from antihyperglycemic drug development. American Heart Journal 215, pages 178-186.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.